3-{1-[5-chloro-2-(2-ethylbutoxy)benzyl]-5-methyl-1H-pyrazol-3-yl}propanoic acid in crystalline form and methods for use thereof

Patent Number: 9387196

Patent Date: 2016-07-12

Patent type: utility

The present invention provides 3-{1-[5-chloro-2-(2-ethylbutoxy)benzyl]-5-methyl-1H-pyrazol-3-yl}propanoicacid in crystalline form. The present invention further provides methods for treating disorders associated with DP<sub>1</sub>, FP, TP, EP<sub>1 </sub>and EP<sub>4 </sub>prostaglandin (PG) receptors.


First Name Last Name City State Country
Gyorgy F. Ambrus - - -
Ke Wu - - -


Section Class Sub Class Group Sub Group
C 07 D 231 12
A 61 K 31 415


Organization First Name Last Name City State Country
Allergan, Inc. - - - - -